Georgia manufacturers advocate for cannabinoid regulation amid legislative uncertainty

In a recent government meeting focused on regulated industries, discussions surrounding the future of cannabinoid manufacturing in Georgia took center stage. Local business owners expressed their concerns about the current legislative climate, which they believe is hindering growth and innovation in the industry.

One manufacturer, who has been in the cannabinoid business for over a year, highlighted the challenges of finding distributors in Georgia. He noted that many potential partners are hesitant to engage due to uncertainty surrounding state regulations. "Everybody's gun shy of doing business in Georgia right now," he stated, emphasizing the need for clearer guidelines to foster a more supportive environment for manufacturers.

The conversation also touched on the differences between various cannabinoids, particularly Delta 8 and Delta 9 THC. The speaker urged lawmakers to conduct thorough research on these substances to ensure they are regulated appropriately. He argued that treating all cannabinoids as the same could lead to misinformation and mismanagement of the industry. "They should all be looked at individually," he said, advocating for a nuanced approach to regulation.

Public health concerns were also a significant topic during the meeting. A representative from Georgians for Responsible Marijuana Policy presented alarming statistics about the rising potency of THC products and their potential impact on public health. He noted that the prevalence of cannabis use disorder has increased, with current estimates suggesting that 3 in 10 users may develop issues related to cannabis use. This statistic raises concerns about the implications for teenagers, who reportedly seek treatment for marijuana use more than for any other substance.

The proposed legislation, SB 254, aims to establish serving size limits for THC products, suggesting a cap of 10 milligrams per serving. This aligns Georgia with several other states that have implemented similar regulations. The representative emphasized the importance of these guardrails to protect public health while allowing the industry to thrive.

As the meeting concluded, the need for ongoing dialogue between lawmakers and industry stakeholders was clear. Business owners expressed their willingness to provide insights and expertise to help shape effective regulations that balance public safety with economic opportunity. The discussions highlighted a pivotal moment for Georgia's cannabinoid industry, as stakeholders seek to navigate the complexities of regulation while fostering a thriving market that benefits both consumers and local businesses.